Our team developed a ByfavoTM launch campaign targeted to anesthesiologists, hospital pharmacists, and PBDM administrators to educate them about the most important aspects of the product: predictability and procedural efficiency. From the simplicity of dosing a single sedative to speed of sedation and overall time to patient discharge, Byfavo helps clinicians improve throughput and turnaround time for each patient. And, because time is of the essence for both product and launch campaign, Avant did it all in approximately 3 months.
By addressing this unmet need for a single sedative appropriate for many patient types, our campaign redefined the standard of care for procedural sedation. Since its launch, Byfavo has tested well among our target audience and received eager adoption by anesthesiologists nationwide.